Corcept Therapeutics Incorporated
Methods for Imaging and Treatment of Somatostatin-Receptor Positive Tumors
Last updated:
Abstract:
Methods for treating, identifying and localizing tumors expressing somatostatin receptors (SRs), including methods of enhancing the efficacy of imaging techniques by administration of a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (HKGRM) effective to increase SR expression in tumors. HKGRM administration for enhancing SR-based tumor imaging and treating neuroendocrine tumors. HKGRM and somatostatin or somatostatin analog combination therapy for treating and enhancing SR-based tumor imaging.
Status:
Application
Type:
Utility
Filling date:
19 Dec 2019
Issue date:
3 Mar 2022